STOCK TITAN

AdaptHealth Corp. to Participate in Upcoming Investor Conference

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Key Terms

continuous glucose monitors medical
A continuous glucose monitor is a small wearable device with a sensor placed just under the skin that measures blood-sugar levels around the clock and sends those readings to a display or smartphone — like a fitness tracker for glucose. Investors care because adoption and repeat purchases of sensors and supplies create steady revenue, while clinical usefulness, pricing, insurance coverage and regulatory approval determine how fast and widely the devices sell.
insulin pumps medical
Insulin pumps are small wearable devices that deliver measured doses of insulin under the skin throughout the day to help people with diabetes keep their blood sugar within target ranges. They matter to investors because they represent a recurring-revenue medical device market driven by device sales, disposable supplies, and software services, with value tied to regulatory approvals, insurance coverage, clinical benefits and patient adoption — like a programmable, ongoing delivery system replacing manual injections.
chronic obstructive pulmonary disease medical
Chronic obstructive pulmonary disease (COPD) is a long-lasting lung condition that makes breathing progressively harder by narrowing airways and destroying air sacs, like an increasingly clogged and leaky air pipe. It matters to investors because COPD represents a large, growing market for treatments, diagnostics and medical devices, influences healthcare spending and insurance costs, and is a frequent focus of regulatory reviews and clinical trials that can materially affect company value.
chronic respiratory failure medical
Chronic respiratory failure is a long-term condition in which the lungs cannot reliably bring in enough oxygen or remove enough carbon dioxide, so a person needs ongoing help like supplemental oxygen or breathing devices. For investors, it signals steady demand for drugs, medical devices, home-care services and long-term reimbursement, and outcomes or regulatory changes in this area can meaningfully affect the sales and valuation of companies that provide treatments — much like a broken home heating system that needs continuous repair and replacement parts.
durable medical equipment medical
Durable medical equipment (DME) includes long-lasting devices used to help people manage health conditions and improve mobility, such as wheelchairs, hospital beds, and oxygen machines. These items are designed to be reused and are often covered by health insurance. For investors, DME represents a steady market because demand remains consistent as populations age and healthcare needs grow.

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)-- AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the BofA Securities Leveraged Finance Conference, being held in Boca Raton, FL, on Tuesday, December 2, 2025, including a fireside chat at 8:10 a.m. ET. The webcast link will be available on the Company’s website, www.adapthealth.com under “Investor Relations.”

About AdaptHealth Corp.

AdaptHealth is a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including CPAP and BiLevel services) to individuals for the treatment of obstructive sleep apnea. The Respiratory Health segment provides oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services to individuals for the treatment of respiratory diseases, such as chronic obstructive pulmonary disease and chronic respiratory failure. The Diabetes Health segment provides medical devices, including continuous glucose monitors and insulin pumps, and related services to patients for the treatment of diabetes. The Wellness at Home segment provides home medical equipment and services to patients in their homes including those who have been discharged from acute care and other facilities. The segment tailors a service model to patients who are adjusting to new lifestyles or navigating complex disease states by providing essential medical supplies and durable medical equipment.

The Company is proud to partner with an extensive and highly diversified network of referral sources, including acute care hospitals, sleep labs, pulmonologists, skilled nursing facilities, and clinics. AdaptHealth services beneficiaries of Medicare, Medicaid, and commercial insurance payors, reaching approximately 4.2 million patients annually in all 50 states through its network of approximately 630 locations in 47 states.

AdaptHealth Corp.

Luke Montgomery, CFA

SVP, Investor Relations

luke.montgomery@adapthealth.com

Investor Relations

ICR Healthcare

IR@adapthealth.com

Source: AdaptHealth Corp.

Adapthealth Corp

NASDAQ:AHCO

AHCO Rankings

AHCO Latest News

AHCO Latest SEC Filings

AHCO Stock Data

1.23B
117.48M
Medical Devices
Services-home Health Care Services
Link
United States
CONSHOHOCKEN